1	Estradiol	Estradiol	B-NP	NN	O	2	SUB	-1
2	increases	increase	B-VP	VBZ	O	0	ROOT	17	increases
3	IL-8	IL-8	B-NP	NN	B-protein	4	NMOD	-1
4	secretion	secretion	I-NP	NN	O	12	NMOD	14	secretion
5	of	of	B-PP	IN	O	4	NMOD	-1
6	normal	normal	B-NP	JJ	O	9	NMOD	-1
7	human	human	I-NP	JJ	O	9	NMOD	-1
8	breast	breast	I-NP	NN	O	9	NMOD	-1
9	tissue	tissue	I-NP	NN	O	5	PMOD	-1
10	and	and	O	CC	O	12	NMOD	-1
11	breast	breast	B-NP	NN	O	12	NMOD	-1
12	cancer	cancer	I-NP	NN	O	2	OBJ	-1
13	in	in	B-ADVP	FW	O	2	VMOD	-1
14	vivo	vivo	I-ADVP	FW	O	13	AMOD	-1
15	.	.	O	.	O	2	P	-1

1	IL-8	IL-8	B-NP	NN	B-protein	3	NMOD	-1
2	or	or	I-NP	CC	O	3	NMOD	-1
3	CXCL8	CXCL8	I-NP	NN	B-protein	4	SUB	-1
4	has	have	B-VP	VBZ	O	0	ROOT	-1
5	been	be	I-VP	VBN	O	4	VC	-1
6	associated	associate	I-VP	VBN	O	5	VC	16	associated
7	with	with	B-PP	IN	O	6	VMOD	-1
8	tumor	tumor	B-NP	NN	O	9	NMOD	-1
9	angiogenesis	angiogenesis	I-NP	NN	O	15	NMOD	3	angiogenesis
10	,	,	O	,	O	15	P	-1
11	metastasis	metastasis	B-NP	NN	O	15	NMOD	14	metastasis
12	,	,	O	,	O	15	P	-1
13	and	and	O	CC	O	15	NMOD	-1
14	poor	poor	B-NP	JJ	O	15	NMOD	-1
15	prognosis	prognosis	I-NP	NN	O	7	PMOD	-1
16	in	in	B-PP	IN	O	15	NMOD	-1
17	breast	breast	B-NP	NN	O	18	NMOD	-1
18	cancer	cancer	I-NP	NN	O	16	PMOD	-1
19	.	.	O	.	O	4	P	-1

1	Estrogen	Estrogen	B-NP	NN	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	crucial	crucial	B-ADJP	JJ	O	2	PRD	17	crucial
4	in	in	B-PP	IN	O	3	AMOD	-1
5	breast	breast	B-NP	NN	O	6	NMOD	-1
6	carcinogenesis	carcinogenesis	I-NP	NN	O	9	NMOD	0
7	and	and	O	CC	O	9	NMOD	-1
8	tumor	tumor	B-NP	NN	O	9	NMOD	-1
9	progression	progression	I-NP	NN	O	4	PMOD	2	progression
10	.	.	O	.	O	2	P	-1

1	Whether	Whether	B-SBAR	IN	O	14	SUB	-1
2	sex	sex	B-NP	NN	O	3	NMOD	-1
3	steroids	steroid	I-NP	NNS	O	4	SUB	-1
4	affect	affect	B-VP	VBP	O	1	SBAR	16	affect
5	IL-8	IL-8	B-NP	NN	B-protein	6	NMOD	-1
6	secretion	secretion	I-NP	NN	O	4	OBJ	14	secretion
7	of	of	B-PP	IN	O	6	NMOD	-1
8	normal	normal	B-NP	JJ	O	10	NMOD	-1
9	breast	breast	I-NP	NN	O	10	NMOD	-1
10	tissue	tissue	I-NP	NN	O	13	NMOD	-1
11	or	or	O	CC	O	13	NMOD	-1
12	breast	breast	B-NP	NN	O	13	NMOD	-1
13	cancer	cancer	I-NP	NN	O	7	PMOD	-1
14	is	be	B-VP	VBZ	O	0	ROOT	-1
15	not	not	I-VP	RB	O	14	VMOD	-1
16	known	know	I-VP	VBN	O	14	VC	-1
17	.	.	O	.	O	14	P	-1

1	Several	Several	B-NP	JJ	O	3	NMOD	-1
2	cell	cell	I-NP	NN	O	3	NMOD	-1
3	types	type	I-NP	NNS	O	0	ROOT	-1
4	in	in	B-PP	IN	O	3	NMOD	-1
5	a	a	B-NP	DT	O	8	NMOD	-1
6	tissue	tissue	I-NP	NN	O	8	NMOD	-1
7	secrete	secrete	I-NP	NN	O	8	NMOD	14	secrete
8	IL-8	IL-8	I-NP	NN	B-protein	4	PMOD	-1
9	.	.	O	.	O	3	P	-1

1	Hence	Hence	B-ADVP	RB	O	7	VMOD	-1
2	,	,	O	,	O	7	P	-1
3	regulatory	regulatory	B-NP	JJ	O	4	NMOD	16	regulatory
4	mechanisms	mechanism	I-NP	NNS	O	7	SUB	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	IL-8	IL-8	B-NP	NN	B-protein	5	PMOD	-1
7	need	need	B-VP	VBP	O	0	ROOT	-1
8	to	to	I-VP	TO	O	9	VMOD	-1
9	be	be	I-VP	VB	O	7	VMOD	-1
10	investigated	investigate	I-VP	VBN	O	9	VC	-1
11	in	in	B-PP	IN	O	10	VMOD	-1
12	whole	whole	B-NP	JJ	O	13	NMOD	-1
13	tissue	tissue	I-NP	NN	O	11	PMOD	-1
14	.	.	O	.	O	7	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	used	use	B-VP	VBD	O	0	ROOT	0
3	microdialysis	microdialysis	B-NP	NN	O	2	OBJ	-1
4	to	to	B-PP	TO	O	2	VMOD	-1
5	sample	sample	B-NP	NN	O	6	NMOD	-1
6	IL-8	IL-8	I-NP	NN	B-protein	4	PMOD	-1
7	in	in	B-PP	IN	O	2	VMOD	-1
8	normal	normal	B-NP	JJ	O	11	NMOD	-1
9	human	human	I-NP	JJ	O	11	NMOD	-1
10	breast	breast	I-NP	NN	O	11	NMOD	-1
11	tissue	tissue	I-NP	NN	O	7	PMOD	-1
12	in	in	B-ADVP	FW	O	11	NMOD	-1
13	situ	situ	I-ADVP	FW	O	12	AMOD	-1
14	in	in	B-PP	IN	O	2	VMOD	-1
15	pre-	pre-	B-NP	JJ	O	18	NMOD	-1
16	and	and	I-NP	CC	O	18	NMOD	-1
17	postmenopausal	postmenopausal	I-NP	JJ	O	18	NMOD	-1
18	women	woman	I-NP	NNS	O	14	PMOD	-1
19	,	,	O	,	O	2	P	-1
20	preoperatively	preoperatively	B-ADVP	RB	O	21	PMOD	-1
21	in	in	B-PP	IN	O	2	VMOD	-1
22	breast	breast	B-NP	NN	O	23	NMOD	-1
23	cancers	cancer	I-NP	NNS	O	21	PMOD	-1
24	of	of	B-PP	IN	O	23	NMOD	-1
25	women	woman	B-NP	NNS	O	24	PMOD	-1
26	,	,	O	,	O	21	P	-1
27	and	and	O	CC	O	21	PMOD	-1
28	in	in	B-PP	IN	O	2	VMOD	-1
29	experimental	experimental	B-NP	JJ	O	31	NMOD	-1
30	breast	breast	I-NP	NN	O	31	NMOD	-1
31	cancer	cancer	I-NP	NN	O	28	PMOD	-1
32	in	in	B-PP	IN	O	31	NMOD	-1
33	mice	mouse	B-NP	NNS	O	32	PMOD	-1
34	.	.	O	.	O	2	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	found	find	B-VP	VBD	O	0	ROOT	0
3	a	a	B-NP	DT	O	6	NMOD	-1
4	significant	significant	I-NP	JJ	O	5	AMOD	-1
5	positive	positive	I-NP	JJ	O	6	NMOD	0
6	correlation	correlation	I-NP	NN	O	2	OBJ	-1
7	between	between	B-PP	IN	O	6	NMOD	-1
8	IL-8	IL-8	B-NP	NN	B-protein	10	NMOD	-1
9	and	and	I-NP	CC	O	10	NMOD	-1
10	estradiol	estradiol	I-NP	NN	O	18	NMOD	-1
11	in	in	B-PP	IN	O	10	NMOD	-1
12	normal	normal	B-NP	JJ	O	14	NMOD	-1
13	breast	breast	I-NP	NN	O	14	NMOD	-1
14	tissue	tissue	I-NP	NN	O	11	PMOD	-1
15	and	and	O	CC	O	18	NMOD	-1
16	hormone-dependent	hormone-dependent	B-NP	JJ	O	18	NMOD	-1
17	breast	breast	I-NP	NN	O	18	NMOD	-1
18	cancer	cancer	I-NP	NN	O	7	PMOD	-1
19	in	in	B-ADVP	FW	O	18	NMOD	-1
20	vivo	vivo	I-ADVP	FW	O	19	AMOD	-1
21	.	.	O	.	O	2	P	-1

1	Ex	Ex	B-ADVP	FW	O	6	VMOD	-1
2	vivo	vivo	I-ADVP	FW	O	1	AMOD	-1
3	,	,	O	,	O	6	P	-1
4	estradiol	estradiol	B-NP	NN	O	5	NMOD	-1
5	exposure	exposure	I-NP	NN	O	6	SUB	19	exposure
6	increased	increase	B-VP	VBD	O	0	ROOT	17	increased
7	the	the	B-NP	DT	O	9	NMOD	-1
8	IL-8	IL-8	I-NP	NN	B-protein	9	NMOD	-1
9	secretion	secretion	I-NP	NN	O	6	OBJ	14	secretion
10	of	of	B-PP	IN	O	9	NMOD	-1
11	normal	normal	B-NP	JJ	O	14	NMOD	-1
12	whole	whole	I-NP	JJ	O	14	NMOD	-1
13	breast	breast	I-NP	NN	O	14	NMOD	-1
14	tissue	tissue	I-NP	NN	O	10	PMOD	-1
15	in	in	B-PP	IN	O	9	NMOD	-1
16	culture	culture	B-NP	NN	O	15	PMOD	19	culture
17	.	.	O	.	O	6	P	-1

1	In	In	B-PP	IN	O	7	VMOD	-1
2	experimental	experimental	B-NP	JJ	O	4	NMOD	-1
3	breast	breast	I-NP	NN	O	4	NMOD	-1
4	cancer	cancer	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	7	P	-1
6	estradiol	estradiol	B-NP	NN	O	7	SUB	-1
7	increased	increase	B-VP	VBD	O	0	ROOT	17	increased
8	IL-8	IL-8	B-NP	NN	B-protein	7	OBJ	-1
9	whereas	whereas	B-PP	IN	O	7	VMOD	-1
10	the	the	B-NP	DT	O	12	NMOD	-1
11	anti-estrogen	anti-estrogen	I-NP	JJ	O	12	NMOD	-1
12	tamoxifen	tamoxifen	I-NP	NN	O	13	SUB	-1
13	inhibited	inhibit	B-VP	VBD	O	9	SBAR	18	inhibited
14	the	the	B-NP	DT	O	15	NMOD	-1
15	secretion	secretion	I-NP	NN	O	13	OBJ	14	secretion
16	of	of	B-PP	IN	O	15	NMOD	-1
17	IL-8	IL-8	B-NP	NN	B-protein	16	PMOD	-1
18	both	both	O	CC	O	15	NMOD	-1
19	in	in	B-ADVP	FW	O	18	DEP	-1
20	vitro	vitro	I-ADVP	FW	O	19	AMOD	-1
21	and	and	O	CC	O	18	DEP	-1
22	extracellularly	extracellularly	B-ADVP	RB	O	18	DEP	-1
23	in	in	B-ADVP	FW	O	18	PMOD	-1
24	vivo	vivo	I-ADVP	FW	O	23	AMOD	-1
25	in	in	B-PP	IN	O	15	NMOD	-1
26	tumors	tumor	B-NP	NNS	O	25	PMOD	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	nude	nude	B-NP	JJ	O	29	NMOD	-1
29	mice	mouse	I-NP	NNS	O	27	PMOD	-1
30	.	.	O	.	O	7	P	-1

1	An	An	B-NP	DT	O	3	NMOD	-1
2	anti-IL-8	anti-IL-8	I-NP	JJ	B-protein	3	NMOD	-1
3	Ab	Ab	I-NP	NN	I-protein	4	SUB	-1
4	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
5	endothelial	endothelial	B-NP	JJ	B-cell_type	7	NMOD	-1
6	cell	cell	I-NP	NN	I-cell_type	7	NMOD	-1
7	proliferation	proliferation	I-NP	NN	O	4	OBJ	1	proliferation
8	induced	induce	B-VP	VBN	O	7	NMOD	17	induced
9	by	by	B-PP	IN	O	8	VMOD	-1
10	cancer	cancer	B-NP	NN	B-cell_type	11	NMOD	-1
11	cell	cell	I-NP	NN	I-cell_type	9	PMOD	-1
12	produced	produce	B-VP	VBD	O	7	NMOD	9	produced
13	IL-8	IL-8	B-NP	NN	B-protein	15	NMOD	-1
14	and	and	I-NP	CC	O	15	NMOD	-1
15	tumors	tumor	I-NP	NNS	O	12	OBJ	-1
16	with	with	B-PP	IN	O	12	VMOD	-1
17	low	low	B-NP	JJ	O	19	NMOD	-1
18	IL-8	IL-8	I-NP	NN	B-protein	19	NMOD	-1
19	levels	level	I-NP	NNS	O	16	PMOD	-1
20	exhibited	exhibit	B-VP	VBD	O	4	VMOD	0
21	decreased	decrease	B-NP	VBN	O	22	NMOD	18	decreased
22	angiogenesis	angiogenesis	I-NP	NN	O	20	OBJ	3	angiogenesis
23	.	.	O	.	O	4	P	-1

1	Our	Our	B-NP	PRP$	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	4	SUB	0
3	strongly	strongly	B-VP	RB	O	4	VMOD	-1
4	suggest	suggest	I-VP	VBP	O	0	ROOT	-1
5	that	that	B-SBAR	IN	O	4	VMOD	-1
6	estradiol	estradiol	B-NP	NN	O	7	SUB	-1
7	has	have	B-VP	VBZ	O	5	SBAR	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	critical	critical	I-NP	JJ	O	10	NMOD	0
10	role	role	I-NP	NN	O	7	OBJ	0
11	in	in	B-PP	IN	O	7	VMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	regulation	regulation	I-NP	NN	O	24	NMOD	16	regulation
14	of	of	B-PP	IN	O	13	NMOD	-1
15	IL-8	IL-8	B-NP	NN	B-protein	14	PMOD	-1
16	in	in	B-PP	IN	O	13	NMOD	-1
17	normal	normal	B-NP	JJ	O	20	NMOD	-1
18	human	human	I-NP	JJ	O	20	NMOD	-1
19	breast	breast	I-NP	NN	O	20	NMOD	-1
20	tissue	tissue	I-NP	NN	O	16	PMOD	-1
21	and	and	O	CC	O	24	NMOD	-1
22	human	human	B-NP	JJ	O	24	NMOD	-1
23	breast	breast	I-NP	NN	O	24	NMOD	-1
24	cancer	cancer	I-NP	NN	O	11	PMOD	-1
25	.	.	O	.	O	4	P	-1

1	IL-8	IL-8	B-NP	NN	B-protein	2	SUB	-1
2	may	may	B-VP	MD	O	0	ROOT	-1
3	present	present	I-VP	VB	O	2	VC	0
4	a	a	B-NP	DT	O	7	NMOD	-1
5	novel	novel	I-NP	JJ	O	6	AMOD	-1
6	therapeutic	therapeutic	I-NP	JJ	O	7	NMOD	-1
7	target	target	I-NP	NN	O	3	OBJ	0
8	for	for	B-PP	IN	O	7	NMOD	-1
9	estrogen	estrogen	B-NP	NN	O	10	AMOD	-1
10	driven	drive	I-NP	VBN	O	15	NMOD	16	driven
11	breast	breast	I-NP	NN	O	12	NMOD	-1
12	carcinogenesis	carcinogenesis	I-NP	NN	O	15	NMOD	0
13	and	and	O	CC	O	15	NMOD	-1
14	tumor	tumor	B-NP	NN	O	15	NMOD	-1
15	progression	progression	I-NP	NN	O	8	PMOD	2	progression
16	.	.	O	.	O	2	P	-1

